Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer
The objective of this study is to examine how adenocarcinoma of the prostate treatment differentially affects African American men's ability to work and to describe and compare changes in work ability (as measured through self-reported global work ability item) reported by African American and white adenocarcinoma of the prostate survivors before treatment and 6 months after treatment completion.
Research Base: Wake Forest University Health Sciences
NCT ID: NCT03963739
NCI Protocol Number: WF-1802
Status: Recruiting
For more information see ClinicalTrials.gov
Interventions
- Interview
- Questionnaire Administration
Condition
Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage II Prostate Cancer, Stage III Prostate Cancer
Trial Type
Supportive Care/Symptom Management/PROs
See a list of participating sites on ClinicalTrials.gov